CD274 and melanoma: Studies using [89Zr]atezolizumab and other anti-mouse PD-L1 mAbs have demonstrated enhanced uptake in irradiated human tumor xenografts in immunocompromised mice and in syngeneic B16F10 melanoma tumors in immunocompetent mice [124,145].